Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2008, p. 4149-4152, Vol. 52, No. 11
0066-4804/08/$08.00+0 doi:10.1128/AAC.00509-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Departments of Medicine and Public Health, Pharmacology Section,1 Surgical and Gastroenterological Sciences, University of Verona, Verona, Italy2
Received 18 April 2008/ Returned for modification 2 July 2008/ Accepted 9 September 2008
Piperacillin-tazobactam was administered as a single dose (4.5 g intravenous) to five patients with stabilized external pancreatic fistula. The penetration into pancreatic juice was prompt, and inhibitory concentrations were achieved and maintained for different periods (0.5 to 6 h) according to bacterial susceptibility and patients' characteristics. Piperacillin and tazobactam showed superimposable pharmacokinetics in both serum and pancreatic juice.
Published ahead of print on 22 September 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»